- €108.73bn
- €118.75bn
- €46.44bn
- 80
- 52
- 34
- 56
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 37,631 | 37,369 | 39,175 | 45,389 | 46,444 |
Cost of Revenue | |||||
Gross Profit | 25,652 | 25,210 | 26,920 | 31,694 | 32,208 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 34,580 | 23,256 | 31,049 | 34,733 | 38,569 |
Operating Profit | 3,051 | 14,113 | 8,126 | 10,656 | 7,875 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,752 | 13,778 | 7,798 | 10,422 | 7,153 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,631 | 11,971 | 6,240 | 8,416 | 5,551 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,754 | 12,294 | 6,223 | 8,371 | 5,400 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,754 | 12,294 | 6,223 | 8,371 | 5,400 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.29 | 10.3 | 5.1 | 5.8 | 5.28 |
Dividends per Share |